Editas Medicine Inc (EDIT) USD0.0001

Sell:$5.21Buy:$5.22$0.21 (4.10%)

NASDAQ:1.58%
Market closed | Prices delayed by at least 15 minutes
Sell:$5.21
Buy:$5.22
Change:$0.21 (4.10%)
Market closed | Prices delayed by at least 15 minutes
Sell:$5.21
Buy:$5.22
Change:$0.21 (4.10%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
4 June 2024
Gilmore Neil O'NeillCEO
Sell
Option/Award related
12,191$5.50$66,996.86315,279
4 June 2024
Baisong MeiOther Level A
Sell
Option/Award related
511$5.50$2,808.25141,032
20 May 2024
Erick LuceraCFO
Sell
Tax related
22,337$5.61$125,404.39116,829
13 May 2024
Jessica HopfieldIndependent Director
Buy
Regular purchase transaction
45,000$5.64$253,867.5067,700
5 March 2024
Gilmore Neil O'NeillCEO
Sell
Tax related
77,824$9.42$732,884.17327,470
4 March 2024
Baisong MeiOther Level A
Sell
Tax related
20,327$9.42$191,425.46141,543
5 December 2023
Bruce E. EatonCTO
Sell
Regular sell transaction (market)
103$10.90$1,122.4174,791
14 November 2023
Bruce E. EatonCTO
Sell
Tax related
695$8.21$5,705.6774,894
7 November 2023
Bruce E. EatonCTO
Sell
Tax related
139$8.40$1,167.6075,589
6 September 2023
Bruce E. EatonCTO
Sell
Tax related
103$8.82$908.4675,728

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 March 2024
Gilmore Neil O'NeillCEO
Sell
Tax related
77,824$9.42$732,884.17327,470
13 May 2024
Jessica HopfieldIndependent Director
Buy
Regular purchase transaction
45,000$5.64$253,867.5067,700
4 March 2024
Baisong MeiOther Level A
Sell
Tax related
20,327$9.42$191,425.46141,543
20 May 2024
Erick LuceraCFO
Sell
Tax related
22,337$5.61$125,404.39116,829
4 June 2024
Gilmore Neil O'NeillCEO
Sell
Option/Award related
12,191$5.50$66,996.86315,279

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.